特定途径的多基因评分大大增加了影响肝脏生物标志物的基因脂肪相互作用的发现
Kenneth E Westerman1, Daniel I Chasman2, W James Gauderman3
1Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA; Programs in Metabolism and Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
HGG advances
|September 13, 2025
概括
路径特定的多基因评分 (pPGS) 揭示了影响肝脏生物标志物的新型基因-脂肪性相互作用. 这些分数提供了比标准多基因分数 (PGS) 更易于解释的发现,以了解复杂的基因环境相互作用.
科学领域:
- 遗传学 遗传学 是一个
- 代谢疾病 代谢疾病
- 生物信息学是一种生物信息学.
背景情况:
- 标准多基因分数 (PGS) 总结了遗传效应,但可以稀释基因环境相互作用的特定途径信号.
- 已知影响肝功能的全基因 PGS × 脂肪性信号,但特定机制的发现仍然有限.
- 全基因组相互作用研究 (GWIS) 面临多重测试负担的挑战.
研究的目的:
- 利用特定途径的多基因分数 (pPGS) 来发现特定机制的基因-脂肪性相互作用.
- 为了研究体质指数 (BMI) 与肝脏生物标志物 (ALT,AST,GGT) 的相互作用,使用ppgs.
- 为了比较PPGS与标准PGS和GWIS的发现能力.
主要方法:
- 使用来自KEGG途径的路径特定多基因分数 (pPGS).
- 对3个肝脏生物标志物 (ALT,AST,GT) 的ppgs和BMI之间的相互作用进行了测试.
- 与标准的全基因组PGS和全基因组相互作用研究 (GWIS) 进行了比较.
主要成果:
- 确定了49个重要的pPGS × BMI对ALT的相互作用,其中80%无法通过GWIS解释.
- 在所有测试的肝脏生物标志物中发现了与83种独特的ppgs的相互作用.
- 证明了选择的途径收集显著影响相互作用的发现.
结论:
- 路径特定的多基因分数 (pPGSs) 能够对肝脏生物标志物的基因-脂肪性相互作用进行强大和可解释的发现.
- 这些发现加强了已知的生物途径 (例如,脂质代谢),并揭示了新的关联 (例如,细胞骨重塑).
- 支持pPGS对未来基因环境相互作用研究在各种暴露和结果中的实用性.
相关概念视频
Polygenic Traits
68.9K
When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
68.9K
Cell Specific Gene Expression
16.3K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.3K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
169
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
169
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
185
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
185
Genome-wide Association Studies-GWAS
15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.3K
Overview of Lipid Metabolism
4.9K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
4.9K


